Mon - Fri 8:00 - 6:30

Wednesday, Nov 11, 2026

HALO NEWS

Health And Legacy Observer • Newsroom
HALO News › Cover Story › Why are fewer Black Americans getting GL...
Advertisement
[ Google AdSense Responsive Leaderboard • 970x90 / 728x90 ]
Cover Story • HALO Reporting

Why are fewer Black Americans getting GLP-1s?

Why are fewer Black Americans getting GLP-1s?

GLP-1s have become the newest celebrity miracle drug, with famous athletes like Serena Williams and Charles Barkley sharing that they’ve used it for weight loss. Drugs like Ozempic and Wegovy have become a status symbol. But before they were famous, GLP-1s were developed to treat Type 2 diabetes, a disease that occurs when a person’s blood sugar becomes too high. It affects nearly 40 million Americans and hits Black Americans especially hard. According to the CDC, about 12 percent of Black adults have diabetes, compared with roughly 7 percent of white adults. Yet when researchers rev...

HALO NEWSLETTER

Join HALO today and unlock this story instantly — It's Free

HALO Observer Insight An independent HALO consumer takeaway — for costs, wellness, or policy context — will appear here automatically for this story. HALO adds this original editorial insight to every syndicated report before publication.
Contributors
Wayne G Fraser headshot
Wayne G Fraser
HALO Contributor
Insurance Broker Insurance Industry
State Georgia, North Carolina, South Carolina
NPN 17934945

Trending Healthcare & Culture Topics — Explore Directory